Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Investor Relations
JTC Team, LLC
Jenene Thomas
T: 908-824-0775
SONN@jtcir.com
Auditor
Cherry Bekaert LLP